People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus for certain participants in recent trials in Africa and Europe A digital ...

Three experimental injectable antiretrovirals – a novel capsid inhibitor and two next-generation integrase inhibitors – could ...

Timothy Ray Brown, known as the "Berlin Patient" and the first person to have been cured of HIV, pictured in 2012. Since the landmark stem cell transplantation which saw Timothy Ray Brown become the ...

Add Yahoo as a preferred source to see more of our stories on Google. Small study shows a promising path toward HIV cure A small, highly anticipated study shows a glimmer of hope in the long effort to ...

A red ribon used for HIV awareness. Australian researchers have found that a medicine used to treat blood cancer can kill 'silent' HIV cells and delay reoccurrence in a milestone pre-clinical ...

Around the world, some 40 million people are living with HIV. And though progress in treatment means the infection isn’t the death sentence it once was, researchers have never been able to bring about ...

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV eradication cure scenarios could consistently reduce new HIV infections among ...

SPOKANE, Wash. – The FDA has approved a twice-yearly injection for HIV prevention following a groundbreaking clinical trial. Years before the approval, Dr. Rachel Safran was part of an original ...